Fortunately for MNTA, the Lovenox patent case can’t be re-litigated based on a change in the standards for inequitable conduct. SNY already appealed its case to the US Supreme Court and, last time I checked, that was the highest court in the land.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”